NCT03048175

Brief Summary

Third molar (wisdom teeth) extraction is one of the most frequent intervention in dentistry. Nevertheless, little is known about the level of general body inflammation of subjects with impacted or semi-impacted third molars. Moreover, The possible effects of surgical removal of wisdom teeth on the overall health are not known. Thus, a study in which 40 subjects has been designed. Twenty subjects were affected by bilateral wisdom tooth pathology necessitating for extraction of both teeth. Control group comprised 20 subjects with absence of wisdom teeth or completely erupted wisdom teeth without pathology associated to or history of previous extraction of both wisdom teeth. In both groups a medical and dental examination will be performed at the baseline and 3 months after baseline for the control group or after the second third molar extraction in the control group. Blood will be also withdrawn to assess systemic inflammation and other systemic parameters. Parameter were evaluated via high sensitive c reactive protein (CRP), lipids, fibrinogen, oxidative stress and endothelial function analysis.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2007

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 19, 2007

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2009

Completed
7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2016

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 6, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 9, 2017

Completed
Last Updated

February 9, 2017

Status Verified

February 1, 2017

Enrollment Period

2.2 years

First QC Date

February 6, 2017

Last Update Submit

February 8, 2017

Conditions

Keywords

C-reactive proteinSystemic inflammationThird molarWisdom tooth

Outcome Measures

Primary Outcomes (1)

  • Changes in C-reactive protein (CRP)

    High-Sensitive plasmatic C-reactive protein

    baseline, 24 and three months after the second extraction

Secondary Outcomes (4)

  • Changes in plasma malondialdehyde (MDA)

    baseline, 24 and three months after the second extraction

  • Changes in lipoperoxides (LOOH)

    baseline, 24 and three months after the second extraction

  • Changes in ferric-reducing antioxidant power (FRAP)

    baseline, 24 and three months after the second extraction

  • Changes in endothelial flow-mediated dilation (FMD) calculated as maximal percentual increase in diameter of the blood vessel above baseline

    baseline, 24 and three months after the second extraction

Study Arms (2)

Cases: wisdom tooth pathology

EXPERIMENTAL

Subjects affected by bilateral wisdom tooth pathology, undergoing surgical removal

Procedure: Wisdom tooth removal

Controls: no wisdom tooth pathology

NO INTERVENTION

Subjects showing agenesia/previous extraction/no symptoms of the lower third molars.

Interventions

After inferior dental and buccal nerve anesthesia a triangular full thickness flap with releasing incision on the mesio-buccal aspect of the second molar is designed. Ostectomy is then performed and tooth is sectioned and gently elevated. Once all the tooth components are extracted, the socket is carefully inspected and flap is sutured with interrupted sutures.

Cases: wisdom tooth pathology

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • cases: bilateral wisdom tooth pathology.
  • control: agenesia/previous extraction/no symptoms of the lower third molars.

You may not qualify if:

  • younger than 18 years and older than 65 years;
  • pregnant or lactating females;
  • females using contraceptive methods;
  • suffering from any systemic illness;
  • patients affected by periodontal disease (radiographic diagnosis of vertical bone defects or bone resorption equal to 20% of the root length);
  • patients with periapical and periradicular radiolucent areas X-ray detectable;
  • patients unable to participate to study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Graziani F, D'Aiuto F, Gennai S, Petrini M, Nisi M, Cirigliano N, Landini L, Bruno RM, Taddei S, Ghiadoni L. Systemic Inflammation after Third Molar Removal: A Case-Control Study. J Dent Res. 2017 Dec;96(13):1505-1512. doi: 10.1177/0022034517722775. Epub 2017 Jul 31.

MeSH Terms

Conditions

Tooth, Impacted

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Code was assigned to each participant. No info on whether they belong to cases or control was given to researchers and statistician.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Case-control intervention trial: cases are treated for pathology. Controls do not have pathology.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 6, 2017

First Posted

February 9, 2017

Study Start

April 19, 2007

Primary Completion

June 15, 2009

Study Completion

June 30, 2016

Last Updated

February 9, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share